Celularity Inc — Director's Dealing 2021

Jul 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GX Acquisition Corp. (CELU)
CIK: 0001752828
Period of Report: 2021-07-16

Reporting Person: Brigido Stephen (Pres, Functional Regeneration)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-16	Stock Option (Right to Buy)	$2.1829	A	20379	Acquired	2031-07-16	Class A Common Stock (20379)	Direct
2021-07-16	Stock Option (Right to Buy)	$2.1829	A	87872	Acquired	2031-07-16	Class A Common Stock (87872)	Direct
2021-07-16	Stock Option (Right to Buy)	$2.1829	A	65846	Acquired	2031-07-16	Class A Common Stock (65846)	Direct
2021-07-16	Stock Option (Right to Buy)	$6.0258	A	76859	Acquired	2031-07-16	Class A Common Stock (76859)	Direct

Footnotes

F1: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, December 15, 2019, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.

F2: This option shall vest and become exercisable over a period of four years from the Vesting Start Date, August 30, 2019, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.

F3: This option is fully vested and exercisable.